Silence Therapeutics (SLN)
NASDAQ: SLN
· Real-Time Price · USD
5.48
-0.15 (-2.66%)
At close: Aug 15, 2025, 3:59 PM
5.49
0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT
Silence Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 26.21M | 38.47M | 16.25M | 17.9M | 26.41M | 25.38M | 28.04M | 28.61M | 23.15M | 17.5M | 16.15M | 15.94M | 14.99M | 12.41M | 8.16M | 6.99M | 4.86M |
Cost of Revenue | 7.07M | 9.23M | 8.97M | 7.8M | 8M | 10.32M | 12.83M | 13.62M | 13.14M | 10.88M | 9.06M | 8.72M | 8.19M | 7.46M | 6.84M | 7.12M | 10.39M |
Gross Profit | 19.14M | 29.24M | 7.27M | 10.1M | 18.41M | 15.06M | 15.21M | 15M | 10.01M | 6.62M | 7.09M | 7.21M | 6.8M | 4.96M | 1.31M | -133K | -5.53M |
Operating Income | -72.35M | -48.09M | -58.31M | -48.48M | -41.61M | -49.6M | -47.27M | -48.19M | -50.82M | -48.59M | -48.9M | -47.56M | -46.4M | -45.81M | -39.18M | -36.46M | -30.63M |
Interest Income | 2.93M | 3.74M | 2.85M | 3.92M | 3.19M | 2.72M | 2.73M | 5.01M | 5.34M | 5.36M | 5.35M | 1.32M | 867K | 519K | 1.23M | 1.08M | 866K |
Pretax Income | -52.39M | -27.23M | -65.93M | -46.43M | -41M | -50.31M | -50.39M | -49.06M | -50.47M | -47.37M | -43.55M | -46.27M | -45.56M | -45.86M | -38.42M | -35.91M | -29.86M |
Net Income | -56.93M | -30.28M | -58.86M | -40.1M | -34.94M | -43.27M | -42.62M | -41.47M | -43.01M | -40.49M | -36.16M | -38.99M | -38.67M | -39.41M | -31.93M | -31.08M | -24.96M |
Selling & General & Admin | 23.97M | 21.45M | 20.17M | 19.53M | 19.36M | 20.64M | 19.99M | 20.86M | 20.29M | 19.61M | 21.55M | 21.2M | 22.03M | 20.01M | 17.09M | 14.29M | 11.49M |
Research & Development | 67.52M | 55.88M | 45.42M | 39.05M | 40.66M | 44.02M | 42.49M | 42.32M | 40.54M | 35.6M | 34.43M | 33.58M | 30.91M | 30.77M | 30.25M | 25.8M | 22.73M |
Other Expenses | -0.00 | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 259K | n/a | -3.09M | n/a | -259K |
Operating Expenses | 91.48M | 77.34M | 65.59M | 58.57M | 60.02M | 64.66M | 62.48M | 63.18M | 60.83M | 55.21M | 55.98M | 54.77M | 53.2M | 50.77M | 44.25M | 40.09M | 33.56M |
Interest Expense | -2.76M | -2.75M | 9.73M | 1.13M | 1.84M | 2.69M | 1.76M | 1.79M | 894K | 34K | 34K | 64K | 64K | 595K | 595K | 650K | 650K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 98.56M | 86.57M | 74.56M | 66.38M | 68.02M | 74.98M | 75.31M | 76.8M | 73.97M | 66.09M | 65.05M | 63.49M | 61.39M | 58.23M | 47.34M | 43.45M | 35.09M |
Income Tax Expense | 4.54M | 3.05M | -7.07M | -6.33M | -6.06M | -7.04M | -7.78M | -7.59M | -7.46M | -6.88M | -7.38M | -7.29M | -6.88M | -6.45M | -6.49M | -4.83M | -2.6M |
Shares Outstanding (Basic) | 47.23M | 47.22M | 46.74M | 46.74M | 43.96M | 38.92M | 37.31M | 36.16M | 35.98M | 32.19M | 32.91M | 29.93M | 29.93M | 29.65M | 29.91M | 29.89M | 28.85M |
Shares Outstanding (Diluted) | 47.23M | 47.22M | 46.74M | 46.74M | 43.96M | 38.92M | 37.31M | 36.16M | 35.98M | 32.19M | 32.91M | 29.93M | 29.93M | 29.65M | 29.91M | 29.89M | 28.85M |
EPS (Basic) | -1.2 | -0.63 | -1.29 | -0.96 | -0.9 | -1.14 | -1.2 | -1.2 | -1.32 | -1.29 | -1.2 | -1.32 | -1.32 | -1.35 | -1.08 | -1.08 | -0.9 |
EPS (Diluted) | -1.2 | -0.63 | -1.29 | -0.96 | -0.9 | -1.14 | -1.2 | -1.2 | -1.32 | -1.29 | -1.2 | -1.32 | -1.32 | -1.35 | -1.08 | -1.08 | -0.9 |
EBITDA | -59.8M | -35.42M | -57.52M | -46.61M | -40.47M | -48.11M | -44.09M | -42.74M | -45.05M | -42.83M | -43.14M | -45.84M | -45.12M | -44.87M | -40.9M | -38.34M | -32.75M |
EBIT | -57.47M | -35.09M | -57.2M | -46.29M | -40.15M | -48.61M | -48.62M | -47.26M | -49.56M | -47.32M | -43.59M | -46.28M | -45.57M | -45.34M | -47.31M | -44.74M | -39.13M |
Depreciation & Amortization | 491.27K | 473.27K | 475K | 485K | 484K | 498K | 518K | 507K | 503K | 482K | 407K | 403K | 412K | 427K | 547K | 533K | 517K |